Literature DB >> 22410778

Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration.

R Palorini1, D De Rasmo, M Gaviraghi, L Sala Danna, A Signorile, C Cirulli, F Chiaradonna, L Alberghina, S Papa.   

Abstract

The Warburg effect in cancer cells has been proposed to involve several mechanisms, including adaptation to hypoxia, oncogenes activation or loss of oncosuppressors and impaired mitochondrial function. In previous papers, it has been shown that K-ras transformed mouse cells are much more sensitive as compared with normal cells to glucose withdrawal (undergoing apoptosis) and present a high glycolytic rate and a strong reduction of mitochondrial complex I. Recent observations suggest that transformed cells have a derangement in the cyclic adenosine monophosphate/cAMP-dependent protein kinase (cAMP/PKA) pathway, which is known to regulate several mitochondrial functions. Herein, the derangement of the cAMP/PKA pathway and its impact on transformation-linked changes of mitochondrial functions is investigated. Exogenous stimulation of PKA activity, achieved by forskolin treatment, protected K-ras-transformed cells from apoptosis induced by glucose deprivation, enhanced complex I activity, intracellular adenosine triphosphate (ATP) levels, mitochondrial fusion and decreased intracellular reactive oxygen species (ROS) levels. Several of these effects were almost completely prevented by inhibiting the PKA activity. Short-time treatment with compounds favoring mitochondrial fusion strongly decreased the cellular ROS levels especially in transformed cells. These findings support the notion that glucose shortage-induced apoptosis, specific of K-ras-transformed cells, is associated to a derangement of PKA signaling that leads to mitochondrial complex I decrease, reduction of ATP formation, prevalence of mitochondrial fission over fusion, and thereby opening new approaches for development of anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22410778     DOI: 10.1038/onc.2012.50

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

Review 1.  Orphan Nuclear Receptors in Colorectal Cancer.

Authors:  Michael E Kelly; Helen M Mohan; Alan W Baird; Elizabeth J Ryan; Des C Winter
Journal:  Pathol Oncol Res       Date:  2018-06-28       Impact factor: 3.201

2.  Transformation by different oncogenes relies on specific metabolic adaptations.

Authors:  Paolo Peruzzo; Marina Comelli; Eros Di Giorgio; Elisa Franforte; Irene Mavelli; Claudio Brancolini
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

3.  Proteomic and Metabolic Analyses of S49 Lymphoma Cells Reveal Novel Regulation of Mitochondria by cAMP and Protein Kinase A.

Authors:  Andrea Wilderman; Yurong Guo; Ajit S Divakaruni; Guy Perkins; Lingzhi Zhang; Anne N Murphy; Susan S Taylor; Paul A Insel
Journal:  J Biol Chem       Date:  2015-07-22       Impact factor: 5.157

4.  Impaired cardiac energy metabolism in embryos lacking adrenergic stimulation.

Authors:  Candice N Baker; Sarah A Gidus; George F Price; Jessica N R Peoples; Steven N Ebert
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

5.  Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers.

Authors:  Yi-Fang Han; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

6.  Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells.

Authors:  Lakshmi Reddy Bollu; Jiangong Ren; Alicia Marie Blessing; Rajasekhara Reddy Katreddy; Guang Gao; Lei Xu; Jinrong Wang; Fei Su; Zhang Weihua
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Disabling mitochondrial reprogramming in cancer.

Authors:  M Cecilia Caino; Dario C Altieri
Journal:  Pharmacol Res       Date:  2015-09-10       Impact factor: 7.658

Review 8.  Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology.

Authors:  Ming Zhan; Craig Brooks; Fuyou Liu; Lin Sun; Zheng Dong
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

9.  Mitochondrial complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death.

Authors:  Roberta Palorini; Tiziana Simonetto; Claudia Cirulli; Ferdinando Chiaradonna
Journal:  Int J Cell Biol       Date:  2013-04-09

10.  Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling.

Authors:  Lilia Alberghina; Daniela Gaglio; Cecilia Gelfi; Rosa M Moresco; Giancarlo Mauri; Paola Bertolazzi; Cristina Messa; Maria C Gilardi; Ferdinando Chiaradonna; Marco Vanoni
Journal:  Front Physiol       Date:  2012-09-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.